Concourse Financial Group Securities, Inc. Xenon Pharmaceuticals Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 2,000 shares of XENE stock, worth $77,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$77,000
Previous $78,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.4MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$218 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$174 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$145 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$112 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$110 Million0.06% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.4B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...